Items per page
1 - 213 of 213
Title Published in Access level OA Policy Year Views Downloads
Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic toolJournal of neurochemistry
accessLevelPublic
2023 96 47
Oral and intestinal dysbiosis in Parkinson's diseaseRevue neurologique
accessLevelPublic
2023 91 24
Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant FormsFrontiers in immunology
accessLevelPublic
2022 225 93
Assessing preoperative hope and expectations related to functional neurosurgery: a new questionnaireBMC psychology
accessLevelPublic
2022 179 85
Electrophysiological confrontation of Lead-DBS-based electrode localizations in patients with Parkinson's disease undergoing deep brain stimulationNeuroImage. Clinical
accessLevelPublic
2022 153 75
Longitudinal study of speech and dual-task performance in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulationParkinsonism & related disorders
accessLevelPublic
2022 152 56
Oral dysbiosis and inflammation in Parkinson's diseaseJournal of Parkinson's Disease
accessLevelPublic
2021 262 623
Robot-induced hallucinations in Parkinson's disease depend on altered sensorimotor processing in fronto-temporal networkScience Translational Medicine
accessLevelRestricted
2021 209 1
Characterisation of advanced Parkinson's disease: OBSERVE-PD observational study – results of the Swiss subgroupSwiss Medical Weekly
accessLevelPublic
2021 149 70
Geospatial analysis of individual-based Parkinson's disease data supports a link with air pollution: a case-control studyParkinsonism & Related Disorders
accessLevelPublic
2021 258 76
Multiomic Analyses of Dopaminergic Neurons Isolated from Human Substantia Nigra in Parkinson's Disease: A Descriptive and Exploratory StudyCellular and molecular neurobiology
accessLevelPublic
2021 197 116
Sensitivity and specificity of an acoustic- and perceptual-based tool for assessing motor speech disorders in French: the MonPaGe-screening protocolClinical Linguistics and Phonetics
accessLevelPublic
2021 210 326
Embarrassment and Shame in People With Parkinson's Disease: A New Tool for Self-AssessmentFrontiers in Neurology
accessLevelPublic
2020 179 109
Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson's disease - the PPMI cohortBMC Neurology
accessLevelPublic
2020 285 106
Illness representations and coping strategies in patients treated with deep brain stimulation for Parkinson's diseaseJournal of Clinical Medicine
accessLevelPublic
2020 392 145
Modeling of electric fields in individual imaging atlas for capsular threshold prediction of deep brain stimulation in Parkinson's disease: a pilot studyFrontiers in Neurology
accessLevelPublic
2020 211 96
Extrastriatal 123I-FP-CIT SPECT impairment in degenerative parkinsonismsParkinsonism & Related Disorders
accessLevelRestricted
2020 376 1
Complex movement disorder in a patient with heterozygous YY1 mutation (Gabriele-de Vries syndrome)American Journal of Medical Genetics. A
accessLevelRestricted
2020 282 1
Natural Killer Cell Alloreactivity Against Human Induced Pluripotent Stem Cells and Their Neuronal Derivatives into Dopaminergic NeuronsStem Cells and Development
accessLevelPrivate
2020 278 0
Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD)Molecular Imaging and Biology
accessLevelRestricted
2020 293 0
Dyskinesia-inducing lead contacts optimize outcome of subthalamic stimulation in Parkinson's diseaseMovement Disorders
accessLevelRestricted
2019 374 2
Education level affects dual-task gait after deep brain stimulation in Parkinson's diseaseParkinsonism & Related Disorders
accessLevelRestricted
2019 339 1
Patient-adjusted deep-brain stimulation programming is time saving in dystonia patientsJournal of Neurology
accessLevelRestricted
2019 334 0
Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal 123I-FP-CIT indicesJournal of Neurology
accessLevelPublic
2019 350 155
Recent developments in drug-induced movement disorders: a mixed pictureThe Lancet Neurology
accessLevelRestricted
2019 322 1
An Empirical Study on the Application of the Burden of Normality to Patients Undergoing Deep Brain Stimulation for Parkinson's DiseaseJournal of Psychosocial Rehabilitation and Mental Health
accessLevelPublic
2019 296 181
The Burden of Normality as a Model of Psychosocial Adjustment After Deep Brain Stimulation for Parkinson's Disease: A Systematic InvestigationNeuropsychology
accessLevelPublic
2019 531 275
Treatment of Drug-Induced ParkinsonismTherapy of Movement Disorders: A Case-Based Approach
accessLevelRestricted
2019 337 0
The Impact of Deep Brain Stimulation for Parkinson's Disease on Couple Satisfaction: An 18-Month Longitudinal StudyJournal of Clinical Psychology in Medical Settings
accessLevelPublic
2019 489 142
The role of molecular imaging in assessing degenerative parkinsonism – an updated reviewSwiss Medical Weekly
accessLevelPublic
2018 692 285
What Is the Best Electrophysiologic Marker of the Outcome of Subthalamic Nucleus Stimulation in Parkinson Disease?World Neurosurgery
accessLevelRestricted
2018 395 0
Maladie de Parkinson au stade avancé : indication aux traitements complexesRevue médicale suisse
accessLevelPublic
2018 566 252
Descriptive epidemiology of parkinsonism in the Canton of Geneva, SwitzerlandParkinsonism & Related Disorders
accessLevelRestricted
2018 414 1
Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective studyJournal of the Neurological Sciences
accessLevelRestricted
2018 521 0
Prevalence of functional (psychogenic) parkinsonism in two Swiss movement disorders clinics and review of the literatureJournal of the Neurological Sciences
accessLevelRestricted
2018 412 1
Cas 5 - Addictions comportementales et apathie dans la maladie de Parkinson: d'un extrême à l'autre13 cas cliniques en neuropsychologie des émotions
2018 334 0
Mouvements anormauxRevue médicale suisse
accessLevelPublic
2018 330 104
Mouvements anormaux aux urgencesRevue médicale suisse
accessLevelPublic
2018 488 309
Combined 123I-FP-CIT SPECT semiquantitative and visual assessment in parkinsonian syndromes and dementia with Lewy bodies - response to Kawada et alJournal of the Neurological Sciences
accessLevelRestricted
2018 403 1
Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind studyMovement Disorders
accessLevelRestricted
2018 597 1
123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System AtrophyClinical Nuclear Medicine
accessLevelRestricted
2018 563 6
Consolidation of a Learned Skill Correlates with Dopamine SPECT Uptake in Early Parkinson's DiseaseJournal of Clinical Neurology
accessLevelPublic
2018 454 195
Localization of Deep Brain Stimulation Contacts Using Corticospinal/Corticobulbar Tracts StimulationFrontiers in neurology
accessLevelPublic
2017 505 242
Life-threatening neuroleptic withdrawal emergent syndrome resembling status dystonicusParkinsonism & related disorders
accessLevelRestricted
2017 591 3
The added value of combined visual and semi-quantitative assessment for (123)I-FP-CIT SPECT and reply to Ueda et alNeurological Sciences
accessLevelRestricted
2017 409 0
Subthalamic nucleus deep brain stimulation for Parkinson's disease in a patient with severe haemophilia AHaemophilia
accessLevelRestricted
2017 360 0
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registryParkinsonism & Related Disorders
accessLevelRestricted
2017 593 0
Added Value of Combined Semi-Quantitative and Visual [123I]FP-CIT SPECT Analyses for the Diagnosis of Dementia With Lewy BodiesClinical nuclear medicine
accessLevelRestricted
2017 552 1
Deep brain stimulation-associated brain tissue imprints: a new in vivo approach to biological research in human Parkinson's diseaseMolecular neurodegeneration
accessLevelPublic
2016 532 235
Discriminating among degenerative parkinsonisms using advanced 123I-ioflupane SPECT analysesNeuroImage. Clinical
accessLevelPublic
2016 606 141
Diabetic Striatopathy in Childhood: A Case ReportPediatrics
accessLevelRestricted
2016 585 1
No more SWEDDsMovement disorders
accessLevelRestricted
2016 476 0
Scan without evidence of dopaminergic deficit: A 10-year retrospective studyParkinsonism & related disorders
accessLevelRestricted
2016 492 0
Establishing On-Site Reference Values for 123I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative ConditionsMolecular imaging and biology
accessLevelRestricted
2016 607 5
Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarctionScientific reports
accessLevelPublic
2016 548 229
Distinct spatiotemporal patterns for disease duration and stage in Parkinson's diseaseEuropean journal of nuclear medicine and molecular imaging
accessLevelRestricted
2016 684 1
Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gaitMovement disorders
accessLevelRestricted
2016 548 1
Diagnostic de la maladie de Parkinson : pas si facile…Revue médicale suisse
accessLevelRestricted
2015 375 1
Stimulation cérébrale profonde et «révolution translationnelle» : le rôle central des cliniciensRevue médicale suisse
accessLevelRestricted
2015 443 0
Ethical Criteria for Human Trials of Stem-Cell-Derived Dopaminergic Neurons in Parkinson's DiseaseAJOB neuroscience
accessLevelRestricted
2015 603 3
Evaluation of electrode position in deep brain stimulation by image fusion (MRI and CT)Neuroradiology
accessLevelRestricted
2015 598 1
Stimulation cérébrale profonde : passé, présent et avenirRevue médicale suisse
accessLevelRestricted
2015 437 1
Stimulation cérébrale profonde lors de maladie de Parkinson et autres troubles du mouvement : indications, résultats et complicationsRevue médicale suisse
accessLevelRestricted
2015 461 2
Neuropathology of Parkinsonism in Alzheimer's diseaseAdvances in experimental medicine and biology
2015 624 1
E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseasesJournal of inflammation
accessLevelPublic
2015 579 226
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosisProteomics. Clinical applications
accessLevelRestricted
2014 782 12
Proteomics as a new paradigm to tackle Parkinson's disease research challengesTranslational proteomics
accessLevelRestricted
2014 560 0
Neuropathology of Parkinsonism in Patients with Pure Alzheimer's DiseaseJournal of Alzheimer's disease
2014 651 0
Acute and subacute drug-induced movement disordersParkinsonism & related disorders
accessLevelRestricted
2014 579 1
2014 recommendations for the treatment of Parkinson's diseaseSchweizer Archiv für Neurologie und Psychiatrie
accessLevelPublic
2014 640 630
Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesisProteomics
accessLevelRestricted
2014 588 5
Transcranial magnetic resonance imaging-guided focused ultrasound in Parkinson's diseaseSchweizer Archiv für Neurologie und Psychiatrie
accessLevelPublic
2014 460 751
A novel approach to reducing number of sensing units for wearable gait analysis systemsIEEE transactions on biomedical engineering
accessLevelRestricted
2013 592 0
Etiologies of Parkinsonism in a century-long autopsy-based cohortBrain pathology
accessLevelRestricted
2013 630 0
Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial resultsEuropean radiology
accessLevelPublic
2013 647 375
Non-dopaminergic drugs for motor symptomsParkinson's Disease
2013 400 0
Neuropathology of dementia in a large cohort of patients with Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2013 593 0
Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementiaClinical nuclear medicine
accessLevelRestricted
2013 710 3
Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2013 617 1
Characterization of the glycated human cerebrospinal fluid proteomeJournal of proteomics
accessLevelRestricted
2012 592 0
Résistances thérapeutiques dans les mouvements anormauxRevue médicale suisse
accessLevelRestricted
2012 488 0
Delayed leukoencephalopathy after alprazolam and methadone overdose: a case report and review of the literatureClinical neurology and neurosurgery
accessLevelRestricted
2012 608 0
Pilomotor seizure: when paroxysmal gooseflesh heralds brain tumorNeurology
accessLevelRestricted
2012 693 0
Blood glutathione S-transferase-π as a time indicator of stroke onsetPloS one
accessLevelPublic
2012 660 312
Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's diseaseJournal of proteomics
accessLevelRestricted
2012 597 0
Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: initial resultsAmerican journal of neuroradiology
accessLevelRestricted
2012 612 0
Diagnosis of and treatment for symptomatic carotid stenosis: an updated reviewActa neurologica Scandinavica
accessLevelRestricted
2012 608 0
Comparison of gel-based methods for the detection of cerebrospinal fluid rhinorrheaClinica chimica acta
accessLevelRestricted
2012 556 0
Neuroproteomics and Parkinson's disease: don't forget human samplesExpert review of proteomics
accessLevelPublic
2011 612 313
A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosisBMC gastroenterology
accessLevelPublic
2011 674 290
VPS35 mutations in Parkinson diseaseAmerican journal of human genetics
accessLevelPublic
2011 685 707
Brain extracellular fluid protein changes in acute stroke patientsJournal of proteome research
accessLevelRestricted
2011 563 0
From relative to absolute quantification of tryptic peptides with tandem mass tags: application to cerebrospinal fluidChimia
2010 625 0
Levodopa in the treatment of Parkinson's disease: an old drug still going strongClinical interventions in aging
accessLevelPublic
2010 1,006 1,053
Stroke severity and residual flow determined by transcranial colour-coded ultrasound (TCCD) predict recanalization and clinical outcome during thrombolysisJournal of the neurological sciences
accessLevelRestricted
2010 578 0
Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesisExpert review of proteomics
accessLevelPublic
2010 463 705
Giant plexiform neurofibroma in neurofibromatosis type 1Archives of neurology
accessLevelRestricted
2010 591 1
Stratégies thérapeutiques dans la maladie de Parkinson avancéeSchweizer Archiv für Neurologie und Psychiatrie
accessLevelPublic
2010 877 685
Zinc-induced copper deficiency in Wilson diseaseJournal of neurology, neurosurgery and psychiatry
accessLevelRestricted
2010 649 0
Virus, lymphocyte et cerveau : une nouvelle problématique neurologiqueRevue médicale suisse
accessLevelRestricted
2009 411 0
Naloxone-responsive acute dystonia and parkinsonism following general anaesthesiaAnaesthesia
accessLevelRestricted
2009 618 0
Retronasal olfactory function in Parkinson's diseaseThe Laryngoscope
accessLevelRestricted
2009 555 0
Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2009 590 0
Restless legs syndrome: an early manifestation of Huntington's disease?Acta neurologica Scandinavica
accessLevelRestricted
2009 628 0
Neuropathological correlates of lower limb corticobasal degenerationNeuropathology and applied neurobiology
accessLevelRestricted
2009 571 0
Autoanticorps en neurologie : implications cliniquesRevue médicale suisse
accessLevelRestricted
2009 510 0
Dyskinesia-induced postural instability in Parkinson's diseaseParkinsonism & related disorders
accessLevelRestricted
2009 505 0
Velocity control in Parkinson's disease: a quantitative analysis of isochrony in scribbling movementsExperimental brain research
accessLevelPublic
2009 532 317
Proteomics in human Parkinson's disease researchJournal of proteomics
accessLevelRestricted
2009 611 0
Pluripotent stem cells as new drugs? The example of Parkinson's diseaseInternational journal of pharmaceutics
accessLevelRestricted
2009 699 3
Foot dystonia as the only manifestation of unilateral nigral atrophyMovement disorders
accessLevelRestricted
2008 550 0
Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effectParkinsonism & related disorders
accessLevelRestricted
2008 574 0
Restless armsLancet
accessLevelRestricted
2008 493 0
Brueghel syndrome as a new manifestation of HIV encephalopathyEuropean neurology
accessLevelRestricted
2008 553 0
L'hystérie : une entité historique, un trouble psychiatrique ou une maladie neurologique ?Revue médicale suisse
2008 624 0
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5Neurology
accessLevelRestricted
2008 587 0
Historique du Service de Neurologie des Hôpitaux Universitaires de GenèveSchweizer Archiv für Neurologie und Psychiatrie
accessLevelRestricted
2008 535 5
NeuropsychiatrieRevue médicale suisse
accessLevelRestricted
2008 489 0
Richtlinien für die Behandlung des idiopathischen ParkinsonsyndromsSchweizer Archiv für Neurologie und Psychiatrie
accessLevelRestricted
2008 523 0
Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulationParkinsonism & related disorders
accessLevelRestricted
2008 420 0
Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndromeClinical science
accessLevelRestricted
2008 707 9
Rhinorrhea and olfaction in Parkinson diseaseNeurology
accessLevelRestricted
2008 551 0
Phantosmias and Parkinson diseaseArchives of neurology
accessLevelRestricted
2008 517 0
Troubles du contrôle des impulsions et maladie de ParkinsonRevue médicale suisse
2008 635 0
Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tagsAnalytical chemistry
accessLevelRestricted
2008 619 0
Human herpesvirus-6 variant A encephalomyelitisNeurology
accessLevelRestricted
2008 623 0
Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantationBone marrow transplantation
accessLevelRestricted
2008 487 0
Compulsive singing: another aspect of punding in Parkinson's diseaseAnnals of neurology
accessLevelRestricted
2007 576 0
Neurologie du système nerveux périphériqueRevue médicale suisse
2007 426 0
Quantification of tremor and bradykinesia in Parkinson's disease using a novel ambulatory monitoring systemIEEE transactions on biomedical engineering
accessLevelRestricted
2007 567 0
Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic strokeBiomarker insights
accessLevelRestricted
2007 574 0
Levodopa-induced ocular dyskinesia in Parkinson's diseaseEuropean Journal of Neurology
accessLevelRestricted
2007 487 0
Downbeat nystagmus as a manifestation of intrathecal morphine toxicityEuropean journal of anaesthesiology
accessLevelRestricted
2007 565 0
Clinical assessment of motor function: a processes oriented instrument based on a speed-accuracy trade-off paradigmBehavioural neurology
accessLevelRestricted
2007 525 2
Is cerebral autoregulation impaired in Parkinson's disease? A transcranial Doppler studyJournal of the neurological sciences
accessLevelRestricted
2007 457 0
Expanding the phenotype of fragile X-associated tremor/ataxia syndrome: a new female caseMovement disorders
accessLevelRestricted
2007 561 0
Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's diseaseMovement disorders
accessLevelRestricted
2007 550 0
Ambulatory monitoring of physical activities in patients with Parkinson's diseaseIEEE transactions on biomedical engineering
accessLevelRestricted
2007 513 0
Age-related proteome analysis of the mouse brain: a 2-DE studyProteomics
accessLevelRestricted
2006 583 0
Revisiter les maladies neurodégénérativesRevue médicale suisse
2006 453 0
State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics researchNature protocols
accessLevelRestricted
2006 578 1
Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?Movement disorders
accessLevelRestricted
2006 604 0
Mécanismes pathogéniques des maladies neurodégénératives : l'exemple de la sclérose latérale amyotrophiqueRevue médicale suisse
2006 484 0
Dégénérescence, régénérescence : un espoir thérapeutique pour la maladie de ParkinsonRevue médicale suisse
2006 500 0
Changes of the cortex proteome and Apolipoprotein E in transgenic mouse models of Alzheimer's DiseaseJournal of chromatography. B
accessLevelRestricted
2006 518 0
Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulationArchives of neurology
accessLevelRestricted
2006 522 0
Fulminant Lewy body diseaseMovement disorders
accessLevelRestricted
2006 605 0
Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluidJournal of proteome research
accessLevelRestricted
2006 618 0
Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?Proteomics
accessLevelRestricted
2005 568 0
Maladie de Wilson : les présentations cliniquesRevue médicale suisse
2005 429 0
Prostaglandin D2 synthase and its post-translational modifications in neurological disordersElectrophoresis
accessLevelRestricted
2005 596 0
Carbamazepine encephalopathy masquerading as Creutzfeldt-Jakob diseaseNeurology
accessLevelRestricted
2005 599 0
Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson diseaseNeurology
accessLevelRestricted
2005 390 1
PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of strokeClinical chemistry
accessLevelRestricted
2005 596 1
Traitement actuel de la maladie de Parkinson : difficultés et controversesRevue médicale suisse
2005 514 0
Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?British journal of dermatology
accessLevelRestricted
2005 553 0
Unis pour le meilleur..Revue médicale suisse
2005 466 0
Suicide after successful deep brain stimulation for movement disordersNeurology
accessLevelRestricted
2004 568 0
Proteomics in clinical neuroscienceBiomedical applications of proteomics
2004 384 0
Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 yearsNeurology
accessLevelRestricted
2004 539 0
Proteomic applications for molecular assessment of Alzheimer's diseaseBiomedical applications of proteomics
2004 348 0
ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic strokeProteomics
accessLevelRestricted
2004 619 0
L-dopa-induced dyskinesia improvement after STN-DBS depends upon medication reductionNeurology
accessLevelRestricted
2004 535 0
Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoringIEEE transactions on biomedical engineering
accessLevelRestricted
2004 470 0
Skull base cerebrospinal fluid fistula: a novel detection method based on two-dimensional electrophoresisHead & neck
accessLevelRestricted
2004 503 0
Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot studyMolecular & cellular proteomics
accessLevelRestricted
2004 559 0
Cerebrospinal fluid tau and Abeta42 concentrations in healthy subjects: delineation of reference intervals and their limitationsClinical chemistry and laboratory medicine
2004 530 0
Phenotypic heterogeneity of dopa-responsive dystonia in monozygotic twinsNeurology
accessLevelRestricted
2004 543 0
Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob diseaseProteomics
accessLevelRestricted
2004 612 0
Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegenerationProteomics
accessLevelRestricted
2004 576 0
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonistsMovement disorders
accessLevelRestricted
2004 527 0
Maladie de Parkinson: description d'un programme interdisciplinaire de rééducation fonctionnelle en groupeRevue médicale de la Suisse romande
2003 599 0
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's diseaseProteomics
accessLevelRestricted
2003 600 0
Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degenerationArchives of neurology
accessLevelRestricted
2003 547 0
How do parkinsonian signs return after discontinuation of subthalamic DBS?Neurology
accessLevelRestricted
2003 583 0
Bilateral optic ischemic neuropathy related to chronic hepatitis C-associated anticardiolipin antibodiesEuropean neurology
accessLevelRestricted
2003 525 0
Causes inhabituelles de troubles de la marcheRevue médicale de la Suisse romande
2003 477 0
The effect of aging on postural stability: a cross sectional and longitudinal studyNeurophysiologie clinique
accessLevelRestricted
2003 499 0
Cas quizRevue médicale de la Suisse romande
2003 462 0
ECG artifact due to deep brain stimulationLancet
accessLevelRestricted
2003 490 0
An ambulatory system to quantify bradykinesia and tremor in Parkinson's diseaseITAB 2003: conference proceedings, 4th International IEEE EMBS Special Topic Conference on Information Technology Applications in Biomedicine, 24-26 April 2003, Birmingham, United Kingdom: new solutions for new challenges
2003 360 0
Microembolic signals and carotid plaque morphology: a study of 71 patients with moderate or high grade carotid stenosisActa neurologica Scandinavica
accessLevelRestricted
2003 504 0
A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob diseaseProteomics
accessLevelRestricted
2003 583 0
Voluntarily simulated tremor in normal subjectsClinical neurophysiology
accessLevelRestricted
2002 511 0
Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathyMetabolic brain disease
accessLevelRestricted
2002 546 0
Analxse cinésiologique de la marche et des mouvements anormauxRevue médicale de la Suisse romande
accessLevelRestricted
2002 388 0
Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14Neurology
accessLevelRestricted
2002 542 0
Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patientsNeurology
accessLevelRestricted
2002 464 1
Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changesTransplant international
accessLevelRestricted
2002 611 0
TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapseBehavioral neuroscience
accessLevelRestricted
2002 437 0
Assessing cerebrospinal fluid rhinorrhea: a two-dimensional electrophoresis approachElectrophoresis
accessLevelRestricted
2001 593 1
Encéphalopathie complexe, transitoire et récidivante après résection étendue de l'intestin grêle. Responsabilité du D-LactateRevue neurologique
2001 533 0
Anti-GAD antibodies and breast cancer in a patient with stiff-person syndrome: a puzzling associationEuropean neurology
accessLevelPublic
2001 555 323
CSF detection of the 14-3-3 protein in unselected patients with dementiaNeurology
accessLevelRestricted
2001 534 0
Lower limb corticobasal degenerationEuropean neurology
accessLevelRestricted
2000 536 0
Bilateral subdural hematomas following routine lumbar diskectomyHeadache
accessLevelRestricted
2000 462 0
Epilepsia cursiva. The forgotten running fitsEuropean neurology
accessLevelRestricted
2000 454 0
Tolcapone-related fulminant hepatitis: electron microscopy shows mitochondrial alterationsDigestive diseases and sciences
accessLevelRestricted
2000 496 0
Proximal myotonic myopathy: clinical, electrophysiological and pathological findings in a familyEuropean neurology
accessLevelRestricted
2000 487 0
Olanzapine-induced neuroleptic malignant syndromeArchives of general psychiatry
accessLevelRestricted
1999 528 0
Quantification of dyskinesia in Parkinson's disease: validation of a novel instrumental methodMovement disorders
accessLevelRestricted
1999 501 0
Plant-induced seizures: reappearance of an old problemJournal of neurology
accessLevelRestricted
1999 601 0
Tolcapone and fulminant hepatitisLancet
accessLevelRestricted
1998 528 0
Stereotactically guided thalamotomy for treatment of parkinsonian tremor isolated to the lower extremity. Case reportJournal of neurosurgery
accessLevelRestricted
1998 431 0
Effet du traitement antirétroviral sur les manifestations électroencéphalographiques et otoneurologiques précoces de l'infection à VIH et signification pronostique des perturbations constatéesNeurophysiologie clinique
accessLevelRestricted
1997 513 1
Discrepancies between HMPAO and ECD SPECT imaging in brain tumorsThe Journal of nuclear medicine
accessLevelPublic
1997 541 177
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM intervalAmerican journal of human genetics
accessLevelPublic
1996 454 308
Paralysie faciale périphérique isolée et infection à VIH: 7 casRevue neurologique
1995 542 0
Ischaemic colitis due to mitochondrial cytopathyLancet
accessLevelRestricted
1995 518 0
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndromeMedicine
accessLevelRestricted
1992 550 0
A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infectionThe New England journal of medicine
accessLevelRestricted
1990 564 0
Photogenic seizures starting with myoclonias without EEG translationReflex seizures and reflex epilepsies: International Symposium on Reflex seizures and Reflex epilepsies, Genève, Suisse, 3-4 juin 1988
1989 370 0
EEG dans 19 cas de SIDA avec atteinte de l'encéphaleNeurophysiologie clinique
accessLevelRestricted
1988 561 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack